3652 results for «355»
3652 results
Andreas Grüntzig Ethica Award ceremony
15 May 2024 – From EuroPCR 2024
This session is the Andreas Grüntzig Ethica Award ceremony.
Imaging and physiology guided PCI
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 clinical case submissions showcasing the use of imaging and physiology guidance during PCI. Cases cover topics such as managing cardiac arrest during PCI, virtual reality-guided PCI, low-contrast PCI in multivessel disease, and the comprehensive assessment of obstructive and non-obstructive coronary...
TAVI and Mitral: Advanced techniques for complex valve interventions
05 Oct 2024 – From AICT-AsiaPCR 2024
Delve into this captivating session showcasing a diverse range of TAVI and mitral valve interventions from the AICT-AsiaPCR 2024 conference. Witness the navigation of complex cases, including a mitral valve-in-ring procedure, a percutaneous mitral commissurotomy in a pregnant patient, and the management of unexpected complications during...
Tricuspid and other interventions for valvular disease
05 Oct 2024 – From AICT-AsiaPCR 2024
Immerse yourself in this captivating session featuring selected clinical case submissions from the AICT-AsiaPCR 2024 conference. Explore a wide range of interventional challenges, including device closure of ruptured sinus of Valsalva aneurysm, balloon valvotomy during pregnancy in a double orifice mitral valve, and unusual femoral complications....
AICT-AsiaPCR 2024 Opening ceremony
04 Oct 2024 – From AICT-AsiaPCR 2024
In the AICT-AsiaPCR 2024 opening ceremony, discover the key figures, explore the programme, and learn about the national societies and working groups involved. Highlights include the Chien Foundation Lifetime Achievement Award in cardiovascular intervention, the nomination of the APSIC Fellows 2024, and insights into Asia Intervention...
AICT-AsiaPCR 2024 Awards ceremony
05 Oct 2024 – From AICT-AsiaPCR 2024
Join us for this exciting awards ceremony, where you'll first meet the three winners selected from 322 candidates across 27 countries who received accolades for the best clinical cases. Witness the presentation of the award-winning case titled 'Percutaneous Intervention of Stuck Prosthetic Mitral Valve'. Following that,...
AICT-AsiaPCR 2024 Closing ceremony
05 Oct 2024 – From AICT-AsiaPCR 2024
As the 2024 edition of AICT-AsiaPCR comes to a close, this special ceremony offers a moment to thank everyone who contributed to its success. It’s a chance to reflect on the highlights and achievements of the event, supported by memorable images, while also offering a preview...
Hybrid procedure: Stent and DCB for a long diffuse lesion - LIVE case
05 Oct 2024 – From AICT-AsiaPCR 2024
A 40-year-old male with no comorbidities presented an NSTEMI. The angiography showed a focus lesion on the mid-CX and a diffuse lesion on the mid and distal LAD. The LAD FFR are 0.49 with a diffuse pullback gradient.
After Stent in mid-CX guided by OCT, the operators...
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
Top Interventional Trials presented at ACC.21
07 Jun 2021
Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21
Author
